Patricia A. Stinchfield, RN, MS, CPNP

NFID President Patricia A. Stinchfield, RN, MS, CPNP

Patricia (Patsy) A. Stinchfield, RN, MS, CPNP is president of the National Foundation for Infectious Diseases (NFID). Throughout her 45-year nursing career, she has focused on infectious disease prevention. She is a frequent national speaker on vaccine hesitancy, vaccinology, and vaccination of healthcare professionals. A pediatric nurse practitioner specializing in vaccine-preventable diseases, she currently has an affiliate faculty position in the School of Nursing at the University of Minnesota. Prior to her retirement in July 2021, she served as senior director of infection prevention and control at Children’s Minnesota, where she remains on professional staff.

Stinchfield is a widely recognized infectious diseases specialist, having served as the first nurse voting member of the Advisory Committee on Immunization Practices (ACIP) where she continues to serve as a liaison member for the National Association of Pediatric Nurse Practitioners and serves on the Influenza and Schedule Work Groups. She was the hospital incident commander for the COVID-19 response at Children’s Minnesota, and led the responses during the H1N1 influenza and the 2017 measles outbreaks. Stinchfield was lead author of a 2020 NFID report on Vitamin A for the Management of Measles in the US. She was instrumental in increasing the staff voluntary flu vaccination rate at Children’s Minnesota to 94 percent and sustained that over several seasons.

Areas of Expertise: 

  • Childhood and adolescent immunizations
  • COVID-19 vaccination
  • Effective communications
  • Flu prevention and treatment
  • Measles prevention and treatment
  • Respiratory syncytial virus (RSV)
  • Vaccine confidence and addressing vaccine hesitancy
  • Vaccination of healthcare professionals


“RSV is a well-known problem in young infants and toddlers—and, certainly, we know that adults can get RSV. But I think the details of the number of hospitalizations and deaths attributable to RSV are not well known, even amongst healthcare providers.” Source: Hospital Infection Control & Prevention

“It’s sort of like we went from the covered wagon to the jet, and so when people get nervous that this [mRNA COVID-19 vaccine development] has gone so fast, well, we didn’t have to grow a virus in eggs, we didn’t have to encourage people to be part of the trials. People wanted to be part of these trials.” Source: WUSA9

“The United States and our vaccine approval process is one of the most transparent models in the world. That’s a really important part that people need to know, that we’re all working on this together. It is transparent. You can ask questions.” Source: Consultant360

“Right now is a perfect time to look at your child’s immunization rates. Talk to your provider. Bring them in now to get caught up if they’re behind, especially those middle school kids. There’s a lot of vaccines [recommended] at 11 and 12 years of age. We want to get them finished because when the COVID-19 vaccine is available for that age group, you can’t give it at the same time as other vaccines.” Source: Good Morning San Diego

“Our communication about COVID-19 risk needs to be proactive, empathetic, transparent, and tailored to each audience.” Source: COVID-19 Communications: Promoting Prevention Measures and Vaccine Confidence (NFID Report)

Patsy Stinchfield on COVID-19 vaccines:

To arrange an interview, contact: Diana Olson,, 301-656-0003 x140

Visit the NFID Newsroom for spokespeople, news conferences, and press releases.

To join the conversation and get the latest news on infectious diseases, follow NFID on Twitter, like us on Facebook, follow us on Instagramvisit us on LinkedIn, and subscribe to receive future NFID Updates.



Updated July 2022